Biochips Can Save Lives In Myocardial Infarction Patients

Time is of the essence in myocardial infarction (MI) patients, as treatment for an MI has to be commenced within the first 12 hours of the acute event to be effective. Biochip multi-markers have been shown to diagnose more MIs within 12 hours of chest pain onset than current diagnostic practice.

Back to news